Combined Increased Chemosensitivity to Hypoxia and Hypercapnia as a Prognosticator in Heart Failure

Journal of the American College of Cardiology

Volumn 53, Issue 21, 2009, Pages 1975-1980

  Giannoni, Alberto ^a,b,c   Emdin, Michele ^a   Bramanti, Francesca ^a   Iudice, Giovanni ^a   Francis, Darrel P ^c   Barsotti, Antonio ^b   Piepoli, Massimo ^d   Passino, Claudio ^e  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c ST MARY S HOSPITAL   (United Kingdom)

^d GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^e SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

arrhythmia; brain natriuretic peptide; chemoreflex; Cheyne Stokes respiration; heart failure; prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARBON DIOXIDE; NORADRENALIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CHEMOSENSITIVITY; CHEYNE STOKES BREATHING; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERCAPNIA; HYPOXIA; LUNG MINUTE VOLUME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REBREATHING; SURVIVAL RATE; SYSTOLIC HEART FAILURE;

ANOXIA; CHEMORECEPTOR CELLS; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HUMANS; HYPERCAPNIA; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; POLYSOMNOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; TIME FACTORS;

EID: 65549113985     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.02.030     Document Type: Article

References (27)

1. The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 26 (2005) 1115-1140
2. Narkiewicz K., Pesek C.A., van de Borne P.J., Kato M., and Somers V.K. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 100 (1999) 262-267
3. Giannoni A., Emdin M., Poletti R., et al. Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. Clin Sci 114 (2008) 489-497
4. Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 341 (1999) 949-954
5. Solin P., Roebuck T., Johns D.P., Walters E.H., and Naughton M.T. Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med 162 (2000) 2194-2200
6. Chua T.P., Clark A.L., Amadi A.A., and Coats A.J. The relationship between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 27 (1996) 650-657
7. Chua T.P., Ponikowski P., Webb-Peploe K., et al. Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex. Eur Heart J 18 (1997) 480-486
8. Ponikowski P., Chua T.P., Anker S.D., et al. Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 104 (2001) 544-549
9. Read D.J. A clinical method for assessing the ventilatory response to carbon dioxide. Australas Ann Med 16 (1967) 20-32
10. Rebuck A.S., and Campbell E.J. A clinical method for assessing the ventilatory response to hypoxia. Am Rev Respir Dis 109 (1974) 345-350
11. Smyth H., Sleight P., and Pickering G. Reflex regulation of arterial pressure during sleep in man. Circ Res 24 (1969) 109-121
12. Mortara A., LaRovere M.T., Pinna G.D., et al. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation 96 (1997) 3450-3458
13. Floras J.S. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 4 Suppl A (1993) 72A-84A
14. Narkiewicz K., Pesek C.A., van de Borne P.J., Kato M., and Somers V.K. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 100 (1999) 262-267
15. Yamada K., Asanoi H., Ueno H., et al. Role of central sympathoexcitation in enhanced hypercapnic chemosensitivity in patients with heart failure. Am Heart J 148 (2004) 964-970
16. Tomita T., Takaki H., Hara Y., et al. Attenuation of hypercapnic carbon dioxide chemosensitivity after postinfarction exercise training: possible contribution to the improvement in exercise hyperventilation. Heart 89 (2003) 404-410
17. Anand I.S., Fisher L.D., Chiang Y.T., and Val-HeFT Investigators. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107 (2003) 1278-1283
18. Gustafsson F., Torp-Pedersen C., Brendorp B., Seibaek M., Burchardt H., Køber L., and DIAMOND Study Group. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J 24 (2003) 863-870
19. 2. Eur Heart J 21 (2000) 154-161
20. Brack T., Thüer I., Clarenbach C.F., et al. Daytime Cheyne-Stokes respiration in ambulatory patients with severe congestive heart failure is associated with increased mortality. Chest 132 (2007) 1463-1471
21. Lanfranchi P.A., Braghiroli A., Bosimini E., et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 99 (1999) 1435-1440
22. Morgan B.J., Crabtree D.C., Palta M., et al. Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans. J Appl Physiol 79 (1995) 205-213
23. Van de Borne P., Oren R., Abouassaly C., Anderson E., and Somers V.K. Effect of Cheyne-Stokes respiration on muscle sympathetic nerve activity in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 81 (1998) 432-436
24. Weil J.V., McCullough R.E., Kline J.S., and Sodal I.E. Diminished ventilator response to hypoxia and hypercapnia after morphine in normal men. N Engl J Med 292 (1975) 1103-1106
25. Chua T.P., Harrington D., Ponikowski P., Webb-Peploe K., Poole-Wilson P.A., and Coats A.J. Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 29 (1997) 147-152
26. Spicuzza L., Bernardi L., Balsamo R., Ciancio N., Polosa R., and Di Maria G. Effect of treatment with nasal continuous positive airway pressure on ventilator response to hypoxia and hypercapnia in patients with sleep apnea syndrome. Chest 130 (2006) 774-779
27. Spicuzza L., Gabutti A., Porta C., Montano N., and Bernardi L. Yoga and chemoreflex response to hypoxia and hypercapnia. Lancet 356 (2000) 1495-1496